Eleven acute and chronic factors were identified for building a risk score model for predicting mortality in patients with dementia.
In a prospective study, the odds of dementia increased nearly 50% with daily use of anticholinergics for 3 years at the minimum effective dose recommended for older adults.
Many adults are worried about developing dementia and about half report taking steps to maintain or improve memory.
The LEAF (Life Enhancing Activities for Family caregivers) intervention may help to reduce the stress of caregiving for a family member with dementia.
Multiple genetic risk loci for Alzheimer disease predict longitudinal cognitive decline in patients with Parkinson disease without dementia.
Researchers sought to identify variables that were associated with suicidal ideation or behavior in patients with Huntington disease.
Kyowa Hakko Kirin announced that the FDA has accepted the resubmitted NDA for istradefylline for use as adjunctive treatment to levodopa/carbidopa in adults with Parkinson disease experiencing OFF episodes.
Mortality attributed to dementia increased from 2000 to 2017, with variation by age, race, and sex.
Diet quality in midlife is not associated with subsequent dementia risk.
The efficacy of cannabinoids on agitation and aggression in patients with Alzheimer disease remains inconclusive, but there might be a benefit with synthetic cannabinoids.